Cargando…

Axitinib in sequential therapy in metastatic renal cell carcinoma

Efficacy of new molecularly targeted drugs in the treatment of renal cell carcinoma (RCC), confirmed in clinical studies in relation to survival and prolongation of time to progression, has became a big chance for patients with metastatic renal cell cancer. Axitinib is a potent and selective recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuchar, Agata, Hryciuk, Beata, Stec, Rafał, Mączewski, Michał, Szczylik, Cezary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371698/
https://www.ncbi.nlm.nih.gov/pubmed/28373826
http://dx.doi.org/10.5114/wo.2015.51823

Ejemplares similares